Duavive - Menopausal disorders
You are here : Home > Formulary Search > Duavive - Menopausal disorders
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
PAD Profile
ChemicalSubstance :
Duavive
Indication :
Menopausal disorders
Group Name :
Keywords :
Menopause, hot sweats, mood swings, anxiety, weight gain, oral tablet, menopausal symptoms, HRT, tissue selective oestrogen complex, hormone replacement therapy, conjugated oestroogen, receptor modulator.
Brand Names Include :
0.45 mg conjugated oestrogens/20 mg bazedoxifene
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Duavive is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Menopausal disorders.
- Clonidine hydrochloride
- Conjugated oestrogens
- Conjugated oestrogens with medroxyprogesterone
- Drospirenone
- Estradiol
- Estradiol with dydrogesterone
- Estradiol with levonorgestrel
- Estradiol with medroxyprogesterone
- Estradiol with norethisterone
- Estradiol with progesterone
- Ethinylestradiol
- Fezolinetant
- Gabapentin
- Levonorgestrel
- Medroxyprogesterone acetate
- Non-Hormonal lubricants
- Paroxetine
- Pregabalin
- Progesterone
- St Johns Wort
- Tibolone
- Venlafaxine
Committee Recommendations (1)
The Surrey & North West Sussex Area Prescribing Committee updated their recommendations in line with NICE guidance NG23 Menopause diagnosis and management in May 2020.
Duavive has been withdrawn from the UK market. Any patient taking Duavive should be reviewed and switched to an alternative preparation.